Kristina Trauger
Capital Markets and M&A Partner, New York
“I advise clients on their most significant corporate transactions and critical board matters.”
Overview
Professional experience
Education and qualifications
Overview
Kristina is a Capital Markets and M&A Partner in Linklaters’ New York office. She advises publicly traded companies, investment banks, and sponsors on a broad range of sophisticated corporate transactions, including equity and debt securities offerings, strategic investments, spin-offs, tender offers, and mergers and acquisitions. She also provides counsel to U.S. and international clients, ranging from newly public companies to established global brands, on corporate governance issues, securities compliance, and SEC reporting obligations.
Kristina is highly experienced in leading clients through the going-public process, as well as a variety of securities financing transactions. These include initial public offerings, follow-on offerings, at-the-market programs, SPAC transactions, private placements, and both investment-grade and high-yield bond issuances.
Her client base spans multiple industries across both domestic and international markets, with sector experience ranging from technology, fintech, and consumer retail to hospitality, energy, healthcare, and biomedical technology.
Work experience
Kristina's recent deal highlights include*:
- Qualtrics in the carve out of Qualtrics from SAP and Qualtrics’ initial public offering raising $1.55 billion and concurrent $670 million private placements.
- Intapp, Inc. in its $314 million initial public offering and multiple follow-on offerings.
- KMG Chemicals, Inc. in multiple equity offerings and on its $1.6 billion sale to Cabot Microelectronics Corporation in a public company merger transaction.
- Intercontinental Exchange Inc. in its acquisition of Ellie Mae from Thoma Bravo for $11 billion.
- Landry’s and Golden Nugget in an offering of $1.415 billion senior secured and unsecured notes and a reorganization that combined the operations of both companies.
- The underwriters and initial purchasers in a convertible senior notes offering and public offering of common stock for Novavax.